Annals of Urologic Oncology

All Articles

  • RESEARCH  |  29 Dec 2019

    Measurement of DNA Damage in Bladder Cancer Patients by Alkaline Comet Assay

    JAHIDUL ISLAM, YEARUL KABIR. Background Bladder cancer is the most common cancer of the urinary tract. DNA damage is responsible for genomic instability, which is a hallmark of bladder carcinogenesis. Cigarette smoking induced DNA damage is one of the major risk factors associated with this disease. Methods We used the alkaline comet assay to measure DNA damage in peripheral blood lymphocytes from...

    Full Text   PDF(1020Kb)

  • REVIEW  |  26 Dec 2019

    Robot-Assisted Radical Cystectomy: State of Art and Future Perspectives

    RICCARDO MASTROIANNI, GIUSPPE SIMONE. Bladder cancer (BC) remains one of the most common cancer worldwide. Radical cystectomy (RC) and pelvic lymph node dissection (PLND) with urinary diversion (UD) is still considered the gold standard treatment for non-metastatic muscle invasive bladder cancer (MIBC) and for recurrent non-muscle invasive disease. The open approach remains the reference option of...

    Full Text   PDF(6080Kb)

  • RESEARCH   |  05 Nov 2019

    Trends in Primary Kidney Cancer: A South Australian Registry Review

    RICHARD HOFFMAN, ARMAN KAHOKEHR, MICHAEL O'CALLAGHAN, KATINA D'ONISE et al. Background The incidence of primary kidney cancer (PKC) has been increasing over the last three decades. This has been attributed to the liberal use of radiological examinations for unrelated indications. We investigated the incidence and survival trends of PKC in South Australia. Methods Data were provided through the So...

    Full Text   PDF(990KB)

  • REVIEW  |  22 Sep 2019

    Mutations in Cancer Driver Genes: An Insight into Prostate Cancer Progression

    SAHDEO PRASAD, SANJAY K SRIVASTAVA. Prostate cancer is one of the most common uro-oncological disease in men and is globally leading cause of cancer related deaths in males. The somatic mutation has a strong link in the occurrence of cancer. Mutation in the oncogenes and tumor suppressor genes that alter key cellular functions can lead to prostate cancer initiation and progression. Whole genome se...

    Full Text   PDF(568KB)

  • REVIEW  |  15 Sep 2019

    Immunotherapy Landscape in Prostate Cancer: Successes, Failures and Promises

    SABEETH-UR-REHMAN BUTT, MUHAMMAD S KHAN, CARMEN MURIAS, MARIA REYES GONZALEZ-EXPOSITO et al. As research focus in oncology has recently shifted to immunomodulation, the era of introduction of immunotherapeutic agents in the management of prostate cancer has just begun. With the success of checkpoint blockade drugs in certain advanced tumours, ongoing efforts are aimed at identification and validat...

    Full Text   PDF(1680KB)

  • REVIEW  |  02 Jul 2019

    Micropapillary Carcinoma of the Bladder: Recent Advances

    JIM HSU, JAE Y. RO. The 2016 WHO classification of tumors of the urothelial tract recently revised the classification of invasive urothelial carcinoma to include nested, microcystic, micropapillary, plasmacytoid, sarcomatoid, giant cell, and poorly differentiated variants, among others. In particular, invasive micropapillary carcinoma (IMPC) is now recognized as a distinct entity with aggressive f...

    Full Text   PDF(4610KB)